Why Big Pharma Quietly Avoids Pregnant Women: The Untold Story About Psychiatric Medications

Medically Reviewed by Dr. Teralyn Sell, PhD

Pregnancy is a time of immense physical, emotional, and psychological change. But here’s the curious part: pharmaceutical companies spend billions marketing psychiatric medications—yet pregnant women are almost completely off the radar. Why would the largest potential market for mental health drugs be intentionally avoided? The answer lies in liability, regulation, and a marketing strategy that keeps this vulnerable population dependent on prescriber guidance rather than informed choice.

The Risk of Misleading Messages

Pregnant women may be told that untreated depression, anxiety, or other psychiatric symptoms could harm them or their baby. While untreated mental health conditions do require attention, the messaging often overstates the benefits of medication and downplays risks, including birth defects, neonatal adaptation syndrome, and potential long-term developmental effects.

Recent FDA Panel on Antidepressants and Pregnancy

In 2025, the FDA convened an expert panel to discuss the safety of selective serotonin reuptake inhibitors (SSRIs) during pregnancy. The panel highlighted potential risks of SSRIs, yet many media outlets immediately spun the discussion as fear mongering. In response, the American Psychiatric Association issued social media messages asserting that antidepressants are completely safe during pregnancy—a statement not supported by full evidence. This selective messaging creates confusion and pressure for pregnant women to take medications without exploring safer alternatives.

Big Pharma’s Silent Strategy

Despite the massive market potential, Big Pharma avoids advertising to pregnant women. Why?

• Liability Risks: Any negative outcomes could lead to lawsuits.

• Regulatory Restrictions: Marketing to pregnant populations is tightly regulated.

• Control Through Prescribers: By leaving pregnant women reliant on doctors for guidance, companies maintain influence without direct exposure.

This silence creates a vacuum that is often filled by prescribers who may overstate safety, social media anecdotes that present skewed norms, and media stories that sensationalize either extreme of medication use.

Downplaying Side Effects

Pharmaceutical marketing also strategically minimizes side effects:

• Severe symptoms are often described as “mild” or “temporary.”

• Ads and prescriber interactions focus on positive outcomes while quickly pivoting away from withdrawal effects, emotional blunting, or neonatal impacts.

• Fine print in commercial disclaimers rarely conveys the full picture.

Why Pregnant Moms Need Informed Choices

Pregnant women deserve clear, unbiased information on psychiatric medications, including:

• Non-pharmacological options like therapy, lifestyle changes, mindfulness, nutrition, and social support.

• Transparent discussion of potential medication side effects for both mother and baby.

• Shared decision-making documented in the medical record.

Final Thoughts

It’s curious but telling that Big Pharma avoids advertising directly to pregnant women while shaping the narrative behind the scenes. Pregnant mothers must advocate for themselves, ask informed questions, and consider non-medication strategies. Awareness of marketing tactics, prescriber bias, and regulatory silence is essential for maternal and fetal health.

Medically Reviewed by Dr. Teralyn Sell, PhD